[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100549615":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":47,"locations":52,"responsibleParty":70,"collaborators":37,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":37,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":37,"enrollmentInfo":81,"targetDuration":37,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":55,"whyStopped":37,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,13,19],{"label":9,"type":6,"description":10,"interventionNames":11},"Controlled group-Blood glucose meters (BGM) group","The participants will receive structured questionnaires and blood tests (glycated albumin, fasting plasma glucose, insulin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein) at 24-32 weeks of pregnancy, 35 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants are required to use blood glucose meters (BGM) at \"24-32 weeks of pregnancy\" and \"33 weeks to before delivery\". After 14 days of glucose monitoring at \"24-32 weeks of pregnancy\", a glucose monitor report will be given to the participants. After the 14 days of glucose monitoring at \"33 weeks to before delivery \", another glucose monitor report will be given to the participants.",[12],"Other: Blood glucose meters (BGM)",{"label":14,"type":15,"description":16,"interventionNames":17},"Experimental group1-Continuous glucose monitoring (CGM) group","EXPERIMENTAL","The participants will receive structured questionnaires and blood tests (glycated albumin, fasting plasma glucose, insulin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein) at 24-32 weeks of pregnancy, 35 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants will receive a set of continuous glucose monitor (CGM) respectively at \"24-32 weeks of pregnancy (first set)\" and \"33 weeks of pregnancy to before delivery (second set)\".",[18],"Device: Continuous glucose monitor",{"label":20,"type":15,"description":21,"interventionNames":22},"Experimental group2-Continuous glucose monitoring (CGM) with nursing care group","The participants will receive structured questionnaires and blood tests (glycated albumin, fasting plasma glucose, insulin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein) at 24-32 weeks of pregnancy, 35 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants will receive a set of continuous glucose monitor (CGM) respectively at \"24-32 weeks of pregnancy (first set)\" and \"33 weeks of pregnancy to before delivery (second set)\".\n\nParticipants will receive perinatal nursing care for gestational diabetes.",[18,23],"Behavioral: Perinatal nursing care for gestational diabetes",[25,32,38],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DEVICE","Continuous glucose monitor","Participants will receive a set of continuous glucose monitor (CGM) at \"24-32 weeks of pregnancy (first set)\" and \"33 weeks of pregnancy to before delivery (second set),\" respectively.\n\nCGM wearing instruction will be provided before the first wearing at \"24-32 weeks of pregnancy\". After completing the first wearing (approximately 14 days after starting to wear), the investigators will provide a glucose monitor report. The second CGM was worn from the 33rd week of pregnancy to before delivery, and another glucose monitor report was given approximately 14 days after starting to wear.",[14,20],[31],"Abbott FreeStyle Libre 2 (CGM)",{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":37},"BEHAVIORAL","Perinatal nursing care for gestational diabetes","Individual nursing care and consultation for pregnant women with gestational diabetes mellitus, including glucose monitor suggestions, dietary suggestions, emotional support, breastfeeding support.",[20],null,{"type":6,"name":39,"description":40,"armGroupLabels":41,"otherNames":37},"Blood glucose meters (BGM)","Participants are required to use blood glucose meters (BGM) at \"24-32 weeks of pregnancy\" and \"33 weeks to before delivery\". After 14 days of glucose monitoring at \"24-32 weeks of pregnancy\", a glucose monitor report will be given to the participants. After the 14 days of glucose monitoring at \"33 weeks to before delivery \", another glucose monitor report will be given to the participants.",[9],[43],{"name":44,"affiliation":45,"role":46},"HUNG-HUI CHEN, PhD","National Taiwan University Hostiptal","PRINCIPAL_INVESTIGATOR",[48],{"name":44,"role":49,"phone":50,"phoneExt":37,"email":51},"CONTACT","886-2-2394-7109","hunghuichen@ntu.edu.tw",[53],{"facility":54,"status":55,"city":56,"state":37,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital","RECRUITING","Hsinchu","302058","Taiwan","TW",{"type":61,"coordinates":62},"Point",[63,64],120.96861,24.80361,{"lat":64,"lon":63},[67],{"name":68,"role":49,"phone":69,"phoneExt":37,"email":51},"HUNG-HUI CHEN","+886-2-23947109",{"type":71,"investigatorFullName":37,"investigatorTitle":37,"investigatorAffiliation":37,"oldNameTitle":37,"oldOrganization":37},"SPONSOR","100549615","the-impact-of-continuous-glucose-monitoring-on-maternal-and-infants-outcomes-in-gestational-diabetes-100549615",false,"NCT06436326","The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes","The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes: Testing the Moderating Effects of Socioeconomic and Cultural Factors","Inclusion Criteria:\n\n* Aged 18 years or above\n* Pregnant women diagnosed with gestational diabetes mellitus\n* Those who are willing to participate in this study\n\nExclusion Criteria:\n\n* Those who have been diagnosed with diabetes mellitus \"before pregnancy\"\n* Those whose skin is likely allergic to some materials such as tapes (signs and symptoms such as redness, swelling, itching, painful, presenting blisters or rashes caused by wearing breathable tapes, patches, etc.)\n* Those who is with abnormal coagulation function","FEMALE","18 Years",{"count":82,"type":83},120,"ESTIMATED","INTERVENTIONAL",[86],"NA","This study will discuss the impact of continuous glucose monitoring on maternal and infant's outcomes in gestational diabetes mellitus, and test the moderating effect of socioeconomic and cultural factors (dietary habits, socioeconomic status and income).",[89,90],"Gestational Diabetes Mellitus","Continuous Glucose Monitoring",[89,90,92],"Health Interventions","2026-06-17",{"date":95,"type":96},"2026-06-22","ACTUAL",{"date":98,"type":96},"2024-08-22",{"date":100,"type":83},"2027-12-31",{"name":5,"class":6},1]